Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tetraphase Pharmaceu (TTPH)

Tetraphase Pharmaceu (TTPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,504
  • Shares Outstanding, K 7,263
  • Annual Sales, $ 7,380 K
  • Annual Income, $ -70,090 K
  • 60-Month Beta 2.06
  • Price/Sales 2.60
  • Price/Cash Flow N/A
  • Price/Book 0.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -1.28
  • Number of Estimates 1
  • High Estimate -1.28
  • Low Estimate -1.28
  • Prior Year -8.40
  • Growth Rate Est. (year over year) +84.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.21 +84.30%
on 04/30/20
3.50 -36.29%
on 05/07/20
+0.97 (+76.98%)
since 04/27/20
3-Month
0.56 +298.21%
on 03/18/20
3.50 -36.29%
on 05/07/20
+0.40 (+21.86%)
since 02/27/20
52-Week
0.56 +298.21%
on 03/18/20
20.60 -89.17%
on 05/29/19
-13.69 (-85.99%)
since 05/24/19

Most Recent Stories

More News
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase

, /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically...

ACRX : 1.5550 (-5.18%)
TTPH : 2.23 (-7.47%)
Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA(TM) (eravacycline for injection) to treat serious and life-threatening...

ACRX : 1.5550 (-5.18%)
TTPH : 2.23 (-7.47%)
SmarTrend Watching for Potential Pullback in Shares of Tetraphase Pharm After 23.91% Gain

Tetraphase Pharm (NASDAQ:TTPH) traded in a range yesterday that spanned from a low of $2.50 to a high of $3.25. Yesterday, the shares gained 23.9%, which took the trading range above the 3-day high of...

TTPH : 2.23 (-7.47%)
Thinking about buying stock in Tetraphase Pharmaceuticals, Surface Oncology, L Brands, Tilray, or Bridgeline Digital?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTPH, SURF, LB, TLRY, and BLIN.

BLIN : 1.7400 (+3.57%)
LB : 17.20 (+3.12%)
SURF : 4.69 (-2.49%)
TTPH : 2.23 (-7.47%)
TLRY : 10.65 (-1.48%)
Tetraphase Announces Determination of Superior Offer and Notice to AcelRx

Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline Xerava(TM) (eravacycline for injection) to treat serious and life-threatening...

ACRX : 1.5550 (-5.18%)
MLNT : 0.4400 (-12.00%)
TTPH : 2.23 (-7.47%)
SmarTrend Watching for Potential Pullback in Shares of Tetraphase Pharm After 31.71% Gain

Tetraphase Pharm (NASDAQ:TTPH) traded in a range yesterday that spanned from a low of $2.03 to a high of $2.53. Yesterday, the shares gained 31.7%, which took the trading range above the 3-day high of...

TTPH : 2.23 (-7.47%)
Thinking about buying stock in Tetraphase Pharmaceuticals, Remark Holdings, Cronos Group, Ford, or Norwegian Cruise Line?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTPH, MARK, CRON, F, and NCLH.

F : 6.03 (+3.25%)
NCLH : 17.59 (+9.73%)
TTPH : 2.23 (-7.47%)
Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss

Catalyst (CPRX) beats on Q1 earnings but misses on revenues. It also withdraws sales guidance due to the coronavirus pandemic.

SPPI : 3.01 (+0.67%)
CNCE : 10.04 (+2.14%)
TTPH : 2.23 (-7.47%)
CPRX : 4.43 (+0.68%)
Tetraphase Pharmaceuticals (TTPH) Reports Q1 Loss, Lags Revenue Estimates

Tetraphase (TTPH) delivered earnings and revenue surprises of 19.63% and -28.37%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

TTPH : 2.23 (-7.47%)
Tetraphase: 1Q Earnings Snapshot

WATERTOWN, Mass. (AP) _ Tetraphase Pharmaceuticals Inc. (TTPH) on Thursday reported a loss of $12.1 million in its first quarter.

TTPH : 2.23 (-7.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade TTPH with:

Business Summary

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug...

See More

Key Turning Points

2nd Resistance Point 2.62
1st Resistance Point 2.43
Last Price 2.23
1st Support Level 2.07
2nd Support Level 1.90

See More

52-Week High 20.60
Fibonacci 61.8% 12.94
Fibonacci 50% 10.58
Fibonacci 38.2% 8.22
Last Price 2.23
52-Week Low 0.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar